Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Broker's Calls

ISDN poised to keep growing on rise in adoption of robotic surgery systems

Stanislaus Jude Chan
Stanislaus Jude Chan • 2 min read
ISDN poised to keep growing on rise in adoption of robotic surgery systems
SINGAPORE (Aug 13): Tayrona Financial, formerly known as NRA Capital, is keeping its “overweight” call on ISDN Holdings with an unchanged fair value estimate of 32 cents, translating to an upside of close to 49% from its current trading price.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Aug 13): Tayrona Financial, formerly known as NRA Capital, is keeping its “overweight” call on ISDN Holdings with an unchanged fair value estimate of 32 cents, translating to an upside of close to 49% from its current trading price.

This comes after the precision motion control and integrated engineering solutions provider reported a 62.1% rise in earnings to $4.9 million for the 2Q18 ended June, compared to $3.0 million a year ago.

2Q18 revenue grew 11.0% to $85.9 million, from $77.4 million a year ago.

This was on the back of sustained growth at its core motion control solutions segment, driven by growing demand for high-tech precision control systems from medical device manufacturers especially in Hong Kong and China.

“We remain bullish on ISDN and see limited downside even if earnings growth were to slow in subsequent quarters. Hence, we maintain our overweight rating with a high-average return and low risk view,” says analyst Liu Jinshu in a Monday report.

The way Liu sees it, ISDN’s downside is further limited by the group’s net cash position of $17.2 million, or 4.4 cents per share.

On the back of ISDN’s strong performance in the first half of 2018, Tayrona has revised its forecasts upwards to expect full-year earnings of $17.3 million, which translates to earnings per share (EPS) of 4.4 cents.

“Growing adoption of robotic surgery systems have led to positive demand for ISDN’s products,” says Liu. “The group is targeting industries such as medical devices, environmental protection, artificial intelligence and electric vehicles for growth opportunities. Capex growth in these industries should provide opportunities for ISDN.”

However, the analyst notes that ISDN has warned that the business climate is starting to show signs of caution, with the semiconductor and electronic sectors appearing to be facing some headwinds following 18 months of growth.

“The semiconductor and electronic sectors only account for a portion of the group’s business and that it has built strong presences in other industries such as infrastructure and medical devices in recent years,” says Liu. “The group’s performance in 3Q18 will give us more visibility to fine-tune forecasts.”

As at 11.34am, shares in ISDN are trading flat at 21.5 cents, implying an estimated price-to-earnings ratio of 5.1 times and a dividend yield of 3.9% for FY18.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.